News
News
- INmune Bio, Inc. Announces Interim Phase Ib Data Demonstrating That XPro1595 Decreases Neuroinflammation in Patients with Alzheimer’s Disease
22:17 - GlobeNewswire - Osmotica Announces Proposed Public Offering of Ordinary Shares
22:15 - GlobeNewswire - Avis Budget Group to Announce Second Quarter 2020 Results on July 28th
22:15 - GlobeNewswire - Synaptics to Report Fourth Quarter Fiscal 2020 Results on August 5, 2020
22:05 - GlobeNewswire - Iterum Therapeutics Informs Shareholders of Record Date for Planned Rights Offering
22:05 - GlobeNewswire - Grindrod Shipping Holdings Ltd. Announces Fleet Update – Re-delivery of Doric Breeze
22:05 - GlobeNewswire - NVE Schedules Conference Call on First-Quarter Results
22:05 - GlobeNewswire - Seacoast Banking Corporation of Florida Announces New Hire, Austen Carroll, to Lead Commercial Banking; Julie Kleffel Promoted to Chief Banking Officer
22:02 - GlobeNewswire - Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
22:01 - GlobeNewswire - Altimmune Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
22:01 - GlobeNewswire
Real-time